26. HTLV-1関連脊髄症 HTLV-1-associated myelopathy Clinical trials / Disease details

臨床試験数 : 29 / 薬物数 : 47 - (DrugBank : 29) / 標的遺伝子数 : 34 - 標的パスウェイ数 : 119

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02655471 (ClinicalTrials.gov)	July 1, 2017	16/11/2015	Effect of Raltegravirin Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Viru ...	Effect of Raltegravirin Patients With Myelopathy/Tropical Spastic Paraparesis Associated With Infect ...	HTLV-I Infections;Tropical Spastic Paraparesis	Drug: Raltegravir and Zidovudine	Universidad Peruana Cayetano Heredia	Merck Sharp & Dohme Corp.	Completed	18 Years	N/A	All	10	Early Phase 1	Peru
2	NCT01867320 (ClinicalTrials.gov)	September 5, 2013	21/5/2013	Raltegravir for HAM/TSP	Pilot Study of Raltegravir, an Integrase Inhibitor, in Human T-Cell Lymphotrophic Virus-1(HTLV-1) As ...	HTLV-I Infection	Drug: Raltegravir	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	18 Years	N/A	All	19	Early Phase 1	United States
3	NCT01620736 (ClinicalTrials.gov)	January 2012	25/1/2012	Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load	Phase II Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load	Human T-cell Leukemia Virus Type 1 Infection	Drug: Raltegravir	Washington University School of Medicine	Merck Sharp & Dohme Corp.	Withdrawn	18 Years	N/A	All	0	Phase 2	United States
4	NCT01000285 (ClinicalTrials.gov)	September 2010	19/10/2009	EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma	Phase I/II Trial of Dose-Adjusted EPOCH Chemotherapy With Bortezomib Combined With Integrase Inhibit ...	Leukemia-Lymphoma, Adult T-Cell	Drug: Bortezomib;Drug: Etoposide;Drug: Vincristine;Drug: Doxorubicin;Drug: Prednisone;Drug: Cyclopho ...	Washington University School of Medicine	NULL	Completed	18 Years	N/A	All	18	Phase 1/Phase 2	United States

First Previous1Next Last